Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Social Media & Business Development Manager

Role Summary

We are seeking a creative and highly motivated Social Media & Business Development Manager to join our team. This position will focus on curating, creating, and managing content for the social media platforms to enhance our online presence, build brand awareness, and engage with our audience. As the Social Media Manager, you will be responsible for developing and executing social media strategies across platforms such as LinkedIn, Instagram, Facebook, and others, ensuring our messaging aligns with the company’s values and business objectives.

Lab Manager

Role Summary

We are seeking a motivated and enthusiastic candidate for the position of lab manager in the antibody field. The successful individual will be responsible for managing and developing lab staff to ensure the effective operation of the antibody lab, devising, and implementing strategies to resolve process improvement issues, and collaborating with other operators to assure efficient and accurate sample handling that meets client needs.

Key Responsibilities

Project Manager, RNA-Drug Discovery

Role Summary 

The project manager is required to provide operational and project management support in the company and during external partnering events. This position plays an important role in the full lifecycle of mRNA therapeutics development from researching, creating new opportunities and building relationships with current/potential clients and strategic partners, providing them with effective solutions, supervising progress project, and managing records and data documents.

Key Responsibilities

Antibody Engineering & Therapeutics (US) 2025

As the annual meeting of the Antibody Society, the Antibody Engineering & Therapeutics has been recognized as one of the top antibody engineering conferences for accelerating next-generation antibodies to commercial success. The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Degraders, Immuno-oncology, T-Cells, VHH and much more... 

2025 NIH Spring Research Vendor Fair

The 2025 NIH Spring Research Vendor Fair is a premier event that brings together leading researchers, innovative contract research organizations, and cutting-edge technology providers in the biomedical research ecosystem. This comprehensive marketplace offers an unparalleled opportunity for professionals to explore the latest advancements in clinical research, discover breakthrough technologies, and network with industry experts from across the United States.

13th Alzheimer’s & Parkinson’s Drug Development Summit

In 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to enable presymptomatic diagnosis, reinvigorating the space with new targets, modalities, and technologies. Meanwhile significant advancements to target the likes of α-synuclein, NLRP3 and GBA suggest only a matter of time until a disease-modifying therapy emerges on the scene for Parkinson’s too.

Scientist Solution Vendor Event - Johns Hopkins

At Johns Hopkins, experts across various disciplines have come together to achieve a new level of precision in health care. Combining the knowledge of specialists from one of the world’s pre-eminent academic medical centers, renowned public health scholars and some of the best systems engineers on planet - Johns Hopkins in Health is continuing to explore and develop precision medicine approaches that will lead to quicker diagnoses, improved treatment and better outcomes. Johns Hopkins School of Medicine was awarded $335M from the National Institutes of Health in 2017.

Subscribe to